Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
暂无分享,去创建一个
S. Waikar | G. McMahon | H. Rennke | K. Costenbader | C. Leatherwood | C. Speyer | K. D’Silva | J. Koopman | Cianna L Leatherwood | Cameron B. Speyer
[1] Paul J. Hoover,et al. Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. , 2019, Seminars in arthritis and rheumatism.
[2] B. Julian,et al. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy , 2019, Front. Immunol..
[3] K. Seyb,et al. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis , 2019, Kidney International.
[4] Hyon K. Choi,et al. All‐Cause and Cause‐Specific Mortality Trends of End‐Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014 , 2019, Arthritis & rheumatology.
[5] G. Xing,et al. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study , 2018, Lupus.
[6] B. Rovin,et al. Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[7] J. Wren,et al. Systemic lupus erythematosus biomarkers: the challenging quest , 2016, Rheumatology.
[8] M. Ward,et al. Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis , 2016, Arthritis & rheumatology.
[9] Anhar Ullah,et al. Prognostic significance of C1q deposition in serial biopsies for predicating the long-term outcome in patients with proliferative lupus nephritis. , 2016, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[10] A. Davidson. What is damaging the kidney in lupus nephritis? , 2016, Nature Reviews Rheumatology.
[11] B. Rovin,et al. Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders , 2015, Lupus Science & Medicine.
[12] D. Birmingham,et al. The Complement System in Lupus Nephritis. , 2015, Seminars in Nephrology.
[13] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] B. Rovin,et al. Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort , 2015, Arthritis & rheumatology.
[15] Yoshiya Tanaka,et al. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. , 2015, Rheumatology.
[16] Kwan-Kyu Park,et al. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. , 2013, International journal of clinical and experimental pathology.
[17] Ming-hui Zhao,et al. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis , 2013, BMC Nephrology.
[18] Glomerular C4d Staining Can Be an Indicator of Disease Activity in Lupus Nephritis , 2013, Renal failure.
[19] T. Utset,et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring , 2011, Arthritis care & research.